Dual effects of poly-alanine mutations in human cortical and interneuron development
Vanesa Nieto-Estevez,Parul Varma,Sara Mirsadeghi,Jimena Caballero,Sergio Gamero-Alameda,Ali Hosseini,Marc J. Silvosa,Drew M. Thodeson,Zane R. Lybrand,Michele Giugliano,Christopher Navara,Jenny Hsieh
DOI: https://doi.org/10.1101/2024.01.25.577271
2024-09-16
Abstract:Infantile spasms, with an incidence of 1.6 to 4.5 per 10,000 live births, are a relentless and devastating childhood epilepsy marked by severe seizures but also leads to lifelong intellectual disability. Alarmingly, up to 5% of males with this condition carry a mutation in the ( ) gene. Our current lack of human-specific models for developmental epilepsy, coupled with discrepancies between animal studies and human data, underscores the gap in knowledge and urgent need for innovative human models, organoids being one of the best available. Here, we used human neural organoid models, cortical organoids (CO) and ganglionic eminences organoids (GEO) which mimic cortical and interneuron development respectively, to study the consequences of PAE mutations, one of the most prevalent mutation in . ARX produces a decrease expression of in GEOs, and an enhancement in interneuron migration. That accelerated migration is cell autonomously driven, and it can be rescued by inhibiting CXCR4. We also found that PAE mutations result in an early increase in radial glia cells and intermediate progenitor cells, followed by a subsequent loss of cortical neurons at later timepoints. Moreover, expression is upregulated in COs derived from patients at 30 DIV and is associated with alterations in the expression of . Furthermore, ARX assembloids had hyperactivity which were evident at early stages of development. With effective treatments for infantile spasms and developmental epilepsies still elusive, delving into the role of ARX mutations in human brain organoids represents a pivotal step toward uncovering groundbreaking therapeutic strategies.
Neuroscience